Line 293: |
Line 293: |
| |eBIDA | | |eBIDA |
| |NPRD | | |NPRD |
− | |Part of SCED pilot. Planning work is in progress, intake form and infrastructure summary received. Databricks expert resource is needed and TC currently does not have this; developers need to leverage Microsoft. Meeting to discuss is being scheduled. | + | |Related to COVID-19 response. Part of SCED pilot. Planning work in progress, intake form and infrastructure summary received. Databricks expert resource is needed. Meeting with Microsoft to discuss. |
| |- | | |- |
| |CARTES | | |CARTES |
Line 301: |
Line 301: |
| |ECATS | | |ECATS |
| |Doing | | |Doing |
− | |Workload Intake Form and architecture diagrams received, currently being reviewed by TC3oE team. | + | |Related to COVID-19 response. Workload Intake Form and architecture diagrams received, currently being reviewed by TC3oE team. |
| |- | | |- |
| |GC Docs | | |GC Docs |
Line 317: |
Line 317: |
| |PGS | | |PGS |
| |Planning | | |Planning |
− | |Part of SCED pilot. Initial interview conducted, data gathering in progress. | + | |Related to COVID-19 response. Part of SCED pilot. Initial interview conducted, data gathering in progress. |
| |- | | |- |
| |RPA CoE | | |RPA CoE |
| |Planning | | |Planning |
− | |Initial interview conducted, data gathering in progress. | + | |Related to COVID-19 response. Initial interview conducted, data gathering in progress. |
| |- | | |- |
| |SAP-BI | | |SAP-BI |
Line 333: |
Line 333: |
| |TCOMS | | |TCOMS |
| |Planning | | |Planning |
− | |Initial interview complete, data gathering in progress. | + | |Related to COVID-19 response. Initial interview complete, data gathering in progress. |
| |- | | |- |
| |TEAMMATE | | |TEAMMATE |
Line 371: |
Line 371: |
| |Digital Signatures | | |Digital Signatures |
| |Not Started | | |Not Started |
− | |SaaS app (DocuSign), will not migrate. | + | |Related to COVID-19 response. SaaS app (DocuSign), will not migrate. |
| |- | | |- |
| |FORMATION | | |FORMATION |
Line 427: |
Line 427: |
| |TSCM | | |TSCM |
| |Not Started | | |Not Started |
− | | | + | |Related to COVID-19 response. |
| |- | | |- |
| |ZAMMAD | | |ZAMMAD |